Abstract Summary The National Osteoporosis Guideline Group (NOGG) has revised the UK
guideline for the assessment and management of osteoporosis and the prevention of …

Osteoporosis is a bone disorder with remarkable changes in bone biologic material and
consequent bone structural distraction, affecting millions of people around the world from …

Objective The objective is to formulate clinical practice guidelines for the pharmacological
management of osteoporosis in postmenopausal women. Conclusions Evidence from …

Abstract Introduction In 2008, the UK National Osteoporosis Guideline Group (NOGG)
produced a guideline on the prevention and treatment of osteoporosis, with an update in …

Osteoporosis is a disease characterized by impaired bone microarchitecture and reduced
bone mineral density (BMD) resulting in bone fragility and increased risk of fracture. In …

Importance Additional therapies are needed for prevention of osteoporotic fractures.
Abaloparatide is a selective activator of the parathyroid hormone type 1 receptor. Objective …

Objective The development of these guidelines is sponsored by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology …

Low back pain (LBP) is one of the major disabling health conditions among older adults
aged 60 years or older. While most causes of LBP among older adults are non-specific and …

Bisphosphonates (BPs) are the most commonly used medications for osteoporosis. This
ASBMR report provides guidance on BP therapy duration with a risk‐benefit perspective …

Guidance is provided in an international setting on the assessment and specific treatment of
postmenopausal women at low, high and very high risk of fragility fractures. Introduction The …